Liver CancerPhase 2NCT07223307
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
MRI-guided adaptive stereotactic ablative body radiotherapy (SABR)
23 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Liver and bile duct23 studies
Liver CancerPhase 2NCT07223307
MRI-guided adaptive stereotactic ablative body radiotherapy (SABR)
Hepatocellular CarcinomaPhase 2NCT04472767
Nivolumab, Ipilimumab, Cabozantinib, Transarterial Chemoembolization
Intrahepatic CholangiocarcinomaPhase 2NCT04891289Papers
Gemcitabine, Oxaliplatin, Dexamethasone, Floxuridine (FUDR)
Hepatocellular CarcinomaPhase 1NCT05003895
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Hepatocellular CarcinomaPhase 2NCT06789757Papers
Memantine Hydrochloride, Bevacizumab, Atezolizumab
Intrahepatic CholangiocarcinomaPhase 2NCT07766187
Histotripsy, Durvalumab, Biopsy
CholangiocarcinomaPhase 2NCT05967182
Pembrolizumab, Gemcitabine, Cisplatin
Intrahepatic CholangiocarcinomaPhase 2NCT06728410
Pemigatinib, Durvalumab
HCC - Hepatocellular CarcinomaPhase 2NCT07586046Papers
Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres
Unresectable Fibrolamellar CarcinomaPhase 1/2NCT04380545Papers
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Locally Advanced Ampulla of Vater CarcinomaPhase 2NCT07780838
Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab
Hepatocellular CarcinomaPhase 2NCT06526338
1.0% IP-001 for injection, Surgical Resection and Local Ablation, Local Ablation Alone
Hepatocellular Carcinoma (HCC)Phase 2NCT07689175
Nivolumab, Ipilimumab (3 mg/kg)
Liver CancerPhase 1NCT04715191
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Locally Advanced Hepatocellular CarcinomaPhase 2NCT05168163
Atezolizumab, Cabozantinib, Lenvatinib
Hepatocellular CarcinomaPhase 2NCT05669339
Irinotecan, Sonidegib, Sorafenib
Refractory Pediatric Solid TumorsPhase 1/2NCT05468359
Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Hepatocellular Carcinoma (HCC)Phase 1NCT07075120Papers
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
Untreated Advanced Biliary Tract CancerPhase 1NCT07107750
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
Unresectable Hepatocellular CarcinomaPhase 1NCT05488522
SBRT With Atezo/Bev for HCC
Unresectable Hepatocellular CarcinomaPhase 1NCT05096715
Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
Advanced Biliary Tract CancerPhase 1NCT06546969
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
Fibrolamellar Hepatocellular Carcinoma (FLC)Phase 1NCT04248569Papers
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma